ミシガン州における動脈硬化の臨床試験
ミシガン州内の拠点で、動脈硬化に関する7件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Profound Research LLC at Cardiology and Vascular Associates - CAVA, Bloomfield Hills
- Profound Research LLC at Millenium Cardiology, Farmington Hills
- Ahmed Arif Medical Research Center (AA MRC LLC ), Flint
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Revival Research Institute, LLC, Dearborn
- Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07157774A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Profound Research LLC, Farmington Hills
被験者募集中第3相
45歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Paragon Health, Inc, Kalamazoo
- Michigan Kidney Consultants, PC, Pontiac
- St. Clair Nephrology Research, Roseville
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Dearborn Heights
- Research Site, Detroit
- Research Site, Farmington Hills
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357Pelacarsen Roll-over Extension Program
- Henry Ford Hospital, Detroit
- Aa Mrc Mhs, Flint
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06875973ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。